investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Michelle Hildebrandt
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Sandra Orsulic
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
Ovary
Kunle O Odunsi
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity
Ovary
Pathology
Joanne F Dorgan
Prospective Study of Serum MIS and Gynecologic Cancer Risk
Ovary
Andre Michael Lieber
Evaluation of Vectors Based on Group B Adenoviruses
Ovary
Pathology
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology
Norman Wolmark
NRG Oncology Network Group Operations Center
Ovary
Radiation Oncology
Surgery / Surgical oncology
Charles Drescher
Pacific Ovarian Cancer Research Consortium
Ovary
Frederick Appelbaum
Cancer Center Support Grant (Comprehensive)
Ovary
Kunle O Odunsi
RPCI-UPCI Ovarian Cancer SPORE
Ovary
